---
schema_version: "secwatch.filing_event.v1"
accession: "0001625101-21-000050"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2021-10-06T23:59:59+00:00"
generated_at: "2026-06-28T22:37:44.244009+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences appoints Laureen DeBuono to board, Kenneth Clark resigns

## Summary
- Kenneth Clark resigned from Board on Oct 4; holds vested options for 150,574 shares at $10.66-$23.08.
- Laureen DeBuono elected to Board; will serve on Audit Committee and chair Nominating Committee.
- DeBuono received initial grant of 32,500 stock options; annual retainers: $40k board, $10k Audit, $10k Nominating Chair.
- Chief Strategy Officer Mr. Levinson designated as an executive officer under the Exchange Act.

## SEC filing metadata
- accession: 0001625101-21-000050
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2021-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/plse-20211004x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625101-21-000050
- JSON: https://secwatch.observer/filing/0001625101-21-000050.json
- Plain text: https://secwatch.observer/filing/0001625101-21-000050.txt

## Key facts
- Executive change
  Laureen DeBuono was elected as Director at PULSE BIOSCIENCES, INC..
  - Action: elected
  - Role: Director
  source text: On October 4, 2021, the Board elected Laureen DeBuono to the Board, effective immediately, to fill the vacancy on the Board resulting from Mr. Clark’s resignation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm
- Executive change
  Kenneth A. Clark resigned as Director at PULSE BIOSCIENCES, INC..
  - Action: resigned
  - Role: Director
  source text: On October 4, 2021, Kenneth A. Clark resigned from the Board of Directors (the “Board”) of Pulse Biosciences, Inc. (the “Company”) and from all committees of the Board for personal reasons.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.